Dr. Gregory Smith MD, MPH, Chief Medical Cannabis Advisor for Callitas Health, Releases New Book on THCV
June 05, 2018 10:32 ET
|
Callitas Health Inc.
CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...
Callitas Health Enters into Exclusive Development and Intellectual Property Agreement for CannaMint Strips and Files Additional Trademarks for CannaStrips and CanRelief
May 24, 2018 08:30 ET
|
Callitas Health Inc.
CINCINNATI, OH, May 24, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health Signs Dr. Gregory Smith MD, MPH, as the Company's Chief Medical Cannabis Advisor
May 21, 2018 10:55 ET
|
Callitas Health Inc.
CINCINNATI, OH, May 21, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health, Inc. Releases Annual Update Letter to Shareholders
April 19, 2018 09:46 ET
|
Callitas Health Inc.
CINCINNATI, OH, April 19, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2) today announced that Interim President and Chief Executive Officer, James Thompson, has...
Callitas Health Announces Selection of TraDigitalIR as Investor and Public Relations Advisor
March 13, 2018 12:10 ET
|
Callitas Health Inc.
CINCINNATI and NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
Callitas Health, Inc Receives Notice of Allowance from USPTO for Patent Application for Treatment for Male Infertility and Sub-Fertility
March 08, 2018 18:17 ET
|
Callitas Health Inc.
CINCINNATI, OH , March 08, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
Callitas Health Inc., Announces New Partnership with NFI Consumer Healthcare's e.p.t. Pregnancy Test Line
March 05, 2018 11:27 ET
|
Callitas Health Inc.
CINCINNATI, OH, March 05, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...